ACHN
Achillion Pharmaceuticals, Inc.
NasdaqGS
People also watch:FOLDACADARIACLDXARRY
8.26-0.14 (-1.73%)
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Prev Close8.40
Open8.35
Bid8.27 x 700
Ask8.28 x 1600
52wk Range5.57 - 10.95
Day's Range8.15 - 8.40
Volume873,942
Avg Vol (3m)1,400,534
As of 11:52 AM EDT. NasdaqGS Real Time Price. Market open.
  • Achillion Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : ACHN-US : July 20, 2016
    Capital Cube8 days ago

    Achillion Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : ACHN-US : July 20, 2016

    Click here to see latest analysis*Disclaimer : This is as of previous day’s closing price.Technical IndicatorsBelow is a quick look at 5 technical indicators for Achillion Pharmaceuticals, Inc.. More studies are available on the Technical Chart.IndicatorSignalClosing Price above/below 50 Day Moving AverageBearishClosing Price above/below 200 Day Moving AverageBullish50 Day Moving Average above/below 200 Day Moving […] (Read more...) The post Achillion Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : ACHN-US : July 20, 2016 appeared first on CapitalCube.

  • Yahoo Finance14 days ago

    Rally powers on as Dow, S&P 500 reach new heights

    Catch The Final Round at 4 p.m. ET with Alexis Christoforous and markets correspondent Nicole Sinclair. Stocks on the move lower include Summit Materials on the pricing of a secondary offering, Achillion Pharmaceuticals, as Chardan Capital Markets initiates coverage with a ‘sell rating’ and Wynn Resorts, with investors taking money off the table after JPMorgan cut its rating to neutral on the casino operator, claiming valuation was lofty at these levels and Macau profit would come down further. The outdoor sports retailer is spiking on a New York Post story that it is close to being sold to Goldman Sachs and Bass Pro Shops.